/Investor DB

Rev1 Ventures — 2016 Investments

4 investments dated 2016 · listed companies and verified rows first · show all

3Bar Biologics3barbiologics.comDec 2016

Columbus, US

Bruce Caldwell(CEO)in

BoardRichard Maksimoski(Director)Rashmi Agnihotri(Director)

Board seatDavid Bergeron· per SEC Form D

Co-investorsS2G Investments

MED-COMPLIANCE IQ, INC.medcomplianceiq.comAug 2016SEC filingmedium confidence

Med-Compliance IQ develops a mobile app that captures wound images and uses patented algorithms to calculate wound area and track healing, serving as a decision-support tool for clinicians treating chronic wounds.

Digital HealthHealthtechMedical DevicesPowell, US

Brett P. Thornton(Executive Officer)Gary J. Ross(Executive Officer, Director)Gary Ross(Chief Executive Officer)Rick Hulse(Chief Technical Officer)

Board seatDavid Bergeron· per SEC Form D · $430K raise · filed Sep 2016

Healthy Rosterhealthyroster.cominSeed · Dec 2016 · $1M

Healthy Roster provides software for athletic trainers to document injuries, run concussion testing, and access continuing education.

Digital HealthSaaSSports TechDublin, US

DAN FRONCZAK(Executive Officer, Director)inNATHAN HEERDT(Executive Officer, Director)inSHAWN PRICE(Executive Officer)in

BoardRYAN HELON(Director)JIM HACKBARTH(Director)

Co-investorsConnetic VenturesJobsOhio VenturesJumpstart VenturesLevel EquityOklahoma Life ScienceTamarind Hill

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Milo Biotechnology

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.